<DOC>
	<DOCNO>NCT02449889</DOCNO>
	<brief_summary>This trial investigate efficacy safety highly purified human chorionic gonadotropin ( HP-hCG ) recombinant human chorionic gonadotropin ( rhCG ) trigger final follicular maturation woman undergo controlled ovarian stimulation</brief_summary>
	<brief_title>A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin ( HP-hCG ) Recombinant Human Chorionic Gonadotropin ( rhCG ) Women Undergoing Controlled Ovarian Stimulation</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Premenopausal females age 18 39 year Documented history infertility Body mass index ( BMI ) 17.5 32.0 kg/m2 Regular menstrual cycle Known endometriosis stage III IV Known polycystic ovarian syndrome ( PCOS ) History recurrent miscarriage History three previous control ovarian stimulation cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>